University Hospitals First in Northeast Ohio to Use New Technology for Lung Cancer Diagnosis

Newswise – CLEVELAND – A new innovation that shows promise to fight lung cancer is now being used at the Cleveland Medical Center of University Hospitals (UH). About 80 percent of lung cancer is diagnosed at an advanced stage, leading to fewer treatment options and more deaths. Auris Health’s Monarch ™ platform enables earlier and more accurate diagnosis of small and hard-to-reach nodules in the periphery of the lung by allowing a physician to view the inside of the lungs and take a tissue sample for biopsy. UH is one of the first hospitals in the United States to use the platform, which was recently approved by the United States Food and Drug Administration (FDA).

“Obtaining a good, accurate biopsy and being able to make an accurate diagnosis will lead to earlier diagnosis and treatment of lung cancer, resulting in better outcomes for patients,” said Benjamin Young, MD, medical director of bronchoscopy at UH Cleveland Medical Center. “This technology is really exciting and a huge step forward in bronchoscope design. With Monarch, we can reach smaller peripheral lung nodules that are now generally inaccessible with current techniques and technology. “

Lung cancer is the leading cause of cancer death worldwide, in part because it has no symptoms in the early stages. Several diagnostic options are currently available for lung cancer, but all have limitations in accuracy, safety, or invasiveness. These limitations can lead to false positives, false negatives, or side effects such as pneumothorax (collapsed lung) and severe bleeding, which can increase healthcare costs and extend hospital stays.

The Monarch platform integrates the latest advancements in robotics, software, data science and endoscopy (the use of small cameras and tools to enter the body through the natural openings). Doctors use the flexible robotic endoscope to navigate to the periphery of the lung with improved range, vision and control. By combining traditional endoscopic images of the lungs with computer-aided navigation based on 3D models of the patient’s own lung anatomy, the Monarch Platform provides clinicians with continuous bronchoscope vision throughout the procedure.

“Compared to current technology, robotic bronchoscopy doubles or triples our ability to successfully sample smaller lesions; the ones we might not even try right now, ”said Dr. Young. “Robotic bronchoscopy allows us to more accurately evaluate incidental findings, eliminating the need for patients to undergo further imaging or additional procedures and eliminating unnecessary doubts and fears.”


About University Hospitals / Cleveland, Ohio Founded in 1866, University Hospitals serve the needs of patients through an integrated network of 23 hospitals (including 5 joint ventures), more than 50 health centers and outpatient clinics, and more than 200 physician offices in 16 counties in northern Ohio. The system’s flagship quaternary care academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine, Oxford University, and the Technion Israel Institute of Technology. The main campus also includes UH Rainbow Babies & Children’s Hospital, which is one of the best children’s hospitals in the country; UH MacDonald Women’s Hospital, the only hospital for women in Ohio; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, with a total research portfolio of more than $ 265 million and more than 3,000 active clinical trials and research studies in progress. The UH Cleveland Medical Center has consistently been one of the best performing studies in national rankings, including “America’s Best Hospitals” by US News & World Report. UH is also home to 19 clinical care and research institutes. UH is one of the largest employers in Northeast Ohio with more than 30,000 employees. Follow UH on LinkedIn, Facebook and Twitter. For more information, visit

Comments are closed.